187 related articles for article (PubMed ID: 17382544)
21. Mannopeptimycins, a novel class of glycopeptide antibiotics active against gram-positive bacteria.
He H
Appl Microbiol Biotechnol; 2005 Jun; 67(4):444-52. PubMed ID: 15702316
[TBL] [Abstract][Full Text] [Related]
22. Discovery of a potent phenolic N1-benzylidene-pyridinecarboxamidrazone selective against Gram-positive bacteria.
Rathbone DL; Parker KJ; Coleman MD; Lambert PA; Billington DC
Bioorg Med Chem Lett; 2006 Feb; 16(4):879-83. PubMed ID: 16298528
[TBL] [Abstract][Full Text] [Related]
23. High-throughput catch-and-release synthesis of oxazoline hydroxamates. Structure-activity relationships in novel inhibitors of Escherichia coli LpxC: in vitro enzyme inhibition and antibacterial properties.
Pirrung MC; Tumey LN; McClerren AL; Raetz CR
J Am Chem Soc; 2003 Feb; 125(6):1575-86. PubMed ID: 12568618
[TBL] [Abstract][Full Text] [Related]
24. Design at the atomic level: design of biaryloxazolidinones as potent orally active antibiotics.
Zhou J; Bhattacharjee A; Chen S; Chen Y; Duffy E; Farmer J; Goldberg J; Hanselmann R; Ippolito JA; Lou R; Orbin A; Oyelere A; Salvino J; Springer D; Tran J; Wang D; Wu Y; Johnson G
Bioorg Med Chem Lett; 2008 Dec; 18(23):6175-8. PubMed ID: 18947996
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and antibacterial activity of novel 5-(4-methyl-1H-1,2,3-triazole) methyl oxazolidinones.
Phillips OA; Udo EE; Abdel-Hamid ME; Varghese R
Eur J Med Chem; 2009 Aug; 44(8):3217-27. PubMed ID: 19376613
[TBL] [Abstract][Full Text] [Related]
26. Antibacterial drug discovery and structure-based design.
Barker JJ
Drug Discov Today; 2006 May; 11(9-10):391-404. PubMed ID: 16635801
[TBL] [Abstract][Full Text] [Related]
27. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
Lu H; Tonge PJ
Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
[TBL] [Abstract][Full Text] [Related]
28. In vitro antibacterial activity of aminosterols against multidrug-resistant bacteria from patients with cystic fibrosis.
Alhanout K; Brunel JM; Raoult D; Rolain JM
J Antimicrob Chemother; 2009 Oct; 64(4):810-4. PubMed ID: 19666647
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis and structure-activity relationships of 6-O-arylpropargyl diazalides with potent activity against multidrug-resistant Streptococcus pneumoniae.
Yong H; Gu YG; Clark RF; Marron T; Ma Z; Soni N; Stone GG; Nilius AM; Marsh K; Djuric SW
Bioorg Med Chem Lett; 2005 May; 15(10):2653-8. PubMed ID: 15863336
[TBL] [Abstract][Full Text] [Related]
30. Antibacterial activity of a novel series of 3-bromo-4-(1H-3-indolyl)-2,5-dihydro-1H-2,5-pyrroledione derivatives--an extended structure-activity relationship study.
Mahboobi S; Eichhorn E; Winkler M; Sellmer A; Möllmann U
Eur J Med Chem; 2008 Mar; 43(3):633-56. PubMed ID: 17624634
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and activity of N-acyl azacyclic urea HIV-1 protease inhibitors with high potency against multiple drug resistant viral strains.
Zhao C; Sham HL; Sun M; Stoll VS; Stewart KD; Lin S; Mo H; Vasavanonda S; Saldivar A; Park C; McDonald EJ; Marsh KC; Klein LL; Kempf DJ; Norbeck DW
Bioorg Med Chem Lett; 2005 Dec; 15(24):5499-503. PubMed ID: 16203141
[TBL] [Abstract][Full Text] [Related]
32. New agents in development for the treatment of bacterial infections.
Abbanat D; Morrow B; Bush K
Curr Opin Pharmacol; 2008 Oct; 8(5):582-92. PubMed ID: 18761107
[TBL] [Abstract][Full Text] [Related]
33. Novel and potent oxazolidinone antibacterials featuring 3-indolylglyoxamide substituents.
Takhi M; Singh G; Murugan C; Thaplyyal N; Maitra S; Bhaskarreddy KM; Amarnath PV; Mallik A; Harisudan T; Trivedi RK; Sreenivas K; Selvakumar N; Iqbal J
Bioorg Med Chem Lett; 2008 Sep; 18(18):5150-5. PubMed ID: 18768315
[TBL] [Abstract][Full Text] [Related]
34. Water-soluble pleuromutilin derivative with excellent in vitro and in vivo antibacterial activity against gram-positive pathogens.
Hirokawa Y; Kinoshita H; Tanaka T; Nakata K; Kitadai N; Fujimoto K; Kashimoto S; Kojima T; Kato S
J Med Chem; 2008 Apr; 51(7):1991-4. PubMed ID: 18330977
[TBL] [Abstract][Full Text] [Related]
35. Bacterial translation inhibitors, 1-acylindazol-3-ols as anthranilic acid mimics.
Stiff C; Graber DR; Thorarensen A; Wakefield BD; Marotti KR; Melchior EP; Sweeney MT; Han F; Rohrer DC; Zurenko GE; Romero DL
Bioorg Med Chem Lett; 2008 Dec; 18(23):6293-7. PubMed ID: 18951783
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and SAR of novel oxazolidinones: discovery of ranbezolid.
Das B; Rudra S; Yadav A; Ray A; Rao AV; Srinivas AS; Soni A; Saini S; Shukla S; Pandya M; Bhateja P; Malhotra S; Mathur T; Arora SK; Rattan A; Mehta A
Bioorg Med Chem Lett; 2005 Oct; 15(19):4261-7. PubMed ID: 16054358
[TBL] [Abstract][Full Text] [Related]
37. A multivalent approach to drug discovery for novel antibiotics.
Long DD; Aggen JB; Christensen BG; Judice JK; Hegde SS; Kaniga K; Krause KM; Linsell MS; Moran EJ; Pace JL
J Antibiot (Tokyo); 2008 Oct; 61(10):595-602. PubMed ID: 19168973
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and antibacterial activity of derivatives of 6-O-allylic acylides.
Xu P; Liu L; Jin Z; Lei P
Bioorg Med Chem Lett; 2007 Jun; 17(12):3330-4. PubMed ID: 17459704
[TBL] [Abstract][Full Text] [Related]
39. Benzenesulfonamide analogs of fluoroquinolones. Antibacterial activity and QSAR studies.
Nieto MJ; Alovero FL; Manzo RH; Mazzieri MR
Eur J Med Chem; 2005 Apr; 40(4):361-9. PubMed ID: 15804535
[TBL] [Abstract][Full Text] [Related]
40. Targeting the forgotten transglycosylases.
Halliday J; McKeveney D; Muldoon C; Rajaratnam P; Meutermans W
Biochem Pharmacol; 2006 Mar; 71(7):957-67. PubMed ID: 16298347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
